CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer

By sjmartinez • March 30, 2025

Huynh JT, Li R, Shin DS. CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CRE25-050. doi: 10.6004/jnccn.2024.7225. PMID: 40154310.

Tags: Fellow, General Internal Medicine, Hematology/Oncology, Publications, Resident

Dietary sodium and potassium intake and risk of diabetes in the Million Veteran Program

Nguyen XT, Li Y, Williams AR, Panigrahy N, Nyaeme MS, Ivey KL, Wang DD, Houghton S, Mahbub H, Willett WC, Hu FB, Gaziano JM, Phillips[...]

Miller Fisher Variant of Guillain-Barré Syndrome Presenting With Dysphagia and Ophthalmoplegia

Sharma R, Murdande S, Garcia-Corella J, Orogian A, Tran L. Miller Fisher Variant of Guillain-Barré Syndrome Presenting With Dysphagia and Ophthalmoplegia. Cureus. 2026 Jan 2;18(1):e100614.[...]

Assessing the Formal Integration of a Student-Run Free Clinic for People Experiencing Homelessness Into a Medical School Curriculum

Zhang F, Burrows A, Allas C, Goldgar S. Assessing the Formal Integration of a Student-Run Free Clinic for People Experiencing Homelessness Into a Medical School[...]